Tourette's Syndrome: Clinical and Neurochemical Correlates

MARK A. RIDDLE, JAMES F. LECKMAN, GEORGE M. ANDERSON, SHARON I. ORT, MAUREEN T. HARDIN, JOHN STEVENSON, DONALD J. COHEN

Research output: Contribution to journalEditorialpeer-review

Abstract

Forty-six patients with Tourette's syndrome (TS), aged 7 to 45 years, were evaluated clinically and neurochemically. Patients with more severe total symptoms had lower plasma homovanillic acid (pHVA) levels. Analysis of individual items on the Tourette Syndrome Global Scale (TSGS) revealed significant inverse correlations between mean pHVA levels and motor restlessness and school/work function. There were no significant correlations between pHVA levels and individual tic items, although the correlation between mean pHVA levels and simple motor tics approached significance. Plasma 3-methyoxy-4-hydroxyphenylglycol (pMHPG) levels did not correlate significantly with TSGS scores. Pretreatment levels of pHVA or pMHPG did not predict treatment response to clonidine. These data suggest that TS patients with more severe non-tic symptomatology have lower morning pHVA levels. This relationship is of interest because earlier studies showed that TS patients have lower CSF HVA levels compared with contrast and control groups. J. Am. Acad. Child Adolesc. Psychiatry, 1988, 27, 4:409–412.

Original languageEnglish (US)
Pages (from-to)409-412
Number of pages4
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume27
Issue number4
DOIs
StatePublished - 1988
Externally publishedYes

Keywords

  • 3-methoxy-4-hydroxyphenylglycol
  • Tourette's syndrome
  • clonidine
  • homovanillic acid

ASJC Scopus subject areas

  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Tourette's Syndrome: Clinical and Neurochemical Correlates'. Together they form a unique fingerprint.

Cite this